Publication

The development of the Screening of Visual Complaints questionnaire for patients with neurodegenerative disorders: Evaluation of psychometric features in a community sample

Huizinga, F., Heutink, J., de Haan, G., van der Lijn, I., van der Feen, F., Vrijling, A., Melis-Dankers, B., de Vries, S., Tucha, O. & Koerts, J., 29-Apr-2020, In : PLOS-One. 15, 4, 24 p., e0232232.

Research output: Contribution to journalArticleAcademicpeer-review

APA

Huizinga, F., Heutink, J., de Haan, G., van der Lijn, I., van der Feen, F., Vrijling, A., Melis-Dankers, B., de Vries, S., Tucha, O., & Koerts, J. (2020). The development of the Screening of Visual Complaints questionnaire for patients with neurodegenerative disorders: Evaluation of psychometric features in a community sample. PLOS-One, 15(4), [e0232232]. https://doi.org/10.1371/journal.pone.0232232

Author

Huizinga, Famke ; Heutink, Joost ; de Haan, Gera ; van der Lijn, Iris ; van der Feen, Fleur ; Vrijling, Anne ; Melis-Dankers, Bart ; de Vries, Stefanie ; Tucha, Oliver ; Koerts, Janneke. / The development of the Screening of Visual Complaints questionnaire for patients with neurodegenerative disorders : Evaluation of psychometric features in a community sample. In: PLOS-One. 2020 ; Vol. 15, No. 4.

Harvard

Huizinga, F, Heutink, J, de Haan, G, van der Lijn, I, van der Feen, F, Vrijling, A, Melis-Dankers, B, de Vries, S, Tucha, O & Koerts, J 2020, 'The development of the Screening of Visual Complaints questionnaire for patients with neurodegenerative disorders: Evaluation of psychometric features in a community sample', PLOS-One, vol. 15, no. 4, e0232232. https://doi.org/10.1371/journal.pone.0232232

Standard

The development of the Screening of Visual Complaints questionnaire for patients with neurodegenerative disorders : Evaluation of psychometric features in a community sample. / Huizinga, Famke; Heutink, Joost; de Haan, Gera; van der Lijn, Iris; van der Feen, Fleur; Vrijling, Anne; Melis-Dankers, Bart; de Vries, Stefanie; Tucha, Oliver; Koerts, Janneke.

In: PLOS-One, Vol. 15, No. 4, e0232232, 29.04.2020.

Research output: Contribution to journalArticleAcademicpeer-review

Vancouver

Huizinga F, Heutink J, de Haan G, van der Lijn I, van der Feen F, Vrijling A et al. The development of the Screening of Visual Complaints questionnaire for patients with neurodegenerative disorders: Evaluation of psychometric features in a community sample. PLOS-One. 2020 Apr 29;15(4). e0232232. https://doi.org/10.1371/journal.pone.0232232


BibTeX

@article{df104e6472574255b31f39c5ac63cc56,
title = "The development of the Screening of Visual Complaints questionnaire for patients with neurodegenerative disorders: Evaluation of psychometric features in a community sample",
abstract = "BACKGROUND AND OBJECTIVES: Patients with neurodegenerative disorders often experience impairments in visual function. In research and clinical care, visual problems are primarily understood as objective visual impairments. Subjective complaints, referring to complaints from a patient's perspective, receive less attention, while they are of utmost clinical importance to guide assessment and rehabilitation. A 21-item Screening of Visual Complaints questionnaire (SVC) was developed for the assessment of subjective visual complaints in patients with neurodegenerative disorders. This prospective study aims to evaluate the psychometric properties of the SVC in a large community sample.METHODS: A stratified convenience sample of 1,461 healthy Dutch participants (18-95 years) without severe self-reported neurological, ophthalmological or psychiatric conditions completed the SVC, Cerebral Visual Complaints questionnaire (CVC-q), National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25), Behavior Rating Inventory of Executive Function-A (BRIEF-A), Questionnaire for Experiences of Attention Deficits (Fragebogen erlebter Defizite der Aufmerkzamkeit; FEDA), Depression Anxiety Stress Scale-21 (DASS-21) and the Structured Inventory for Malingered Symptomatology (SIMS) online. After two weeks, 66 participants completed the SVC again. We evaluated the factor structure, internal consistency, convergent and divergent validity, and test-retest reliability of the SVC.RESULTS: The sample was split in two subsamples to perform exploratory and confirmatory factor analyses. In the first subsample, the exploratory factor analysis extracted three factors from the SVC: diminished visual perception, altered visual perception and ocular discomfort. The confirmatory factor analysis showed this model to be valid in the second subsample. The SVC showed satisfactory convergent validity (NEI-VFQ-25: r = -0.71; CVC-q: r = 0.84) and divergent validity (SIMS: r = 0.26; BRIEF-A: r = 0.29; FEDA: r = 0.40; DASS-21: r = 0.34) and good internal consistency (Cronbach's alpha = 0.85) and test-retest reliability (ICC = 0.82).CONCLUSIONS: The SVC is a valid and reliable tool for the assessment of subjective visual complaints in a community sample and appears promising for clinical use in patients with neurodegenerative disorders.",
author = "Famke Huizinga and Joost Heutink and {de Haan}, Gera and {van der Lijn}, Iris and {van der Feen}, Fleur and Anne Vrijling and Bart Melis-Dankers and {de Vries}, Stefanie and Oliver Tucha and Janneke Koerts",
year = "2020",
month = apr,
day = "29",
doi = "10.1371/journal.pone.0232232",
language = "English",
volume = "15",
journal = "PLOS-One",
issn = "1932-6203",
publisher = "PUBLIC LIBRARY SCIENCE",
number = "4",

}

RIS

TY - JOUR

T1 - The development of the Screening of Visual Complaints questionnaire for patients with neurodegenerative disorders

T2 - Evaluation of psychometric features in a community sample

AU - Huizinga, Famke

AU - Heutink, Joost

AU - de Haan, Gera

AU - van der Lijn, Iris

AU - van der Feen, Fleur

AU - Vrijling, Anne

AU - Melis-Dankers, Bart

AU - de Vries, Stefanie

AU - Tucha, Oliver

AU - Koerts, Janneke

PY - 2020/4/29

Y1 - 2020/4/29

N2 - BACKGROUND AND OBJECTIVES: Patients with neurodegenerative disorders often experience impairments in visual function. In research and clinical care, visual problems are primarily understood as objective visual impairments. Subjective complaints, referring to complaints from a patient's perspective, receive less attention, while they are of utmost clinical importance to guide assessment and rehabilitation. A 21-item Screening of Visual Complaints questionnaire (SVC) was developed for the assessment of subjective visual complaints in patients with neurodegenerative disorders. This prospective study aims to evaluate the psychometric properties of the SVC in a large community sample.METHODS: A stratified convenience sample of 1,461 healthy Dutch participants (18-95 years) without severe self-reported neurological, ophthalmological or psychiatric conditions completed the SVC, Cerebral Visual Complaints questionnaire (CVC-q), National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25), Behavior Rating Inventory of Executive Function-A (BRIEF-A), Questionnaire for Experiences of Attention Deficits (Fragebogen erlebter Defizite der Aufmerkzamkeit; FEDA), Depression Anxiety Stress Scale-21 (DASS-21) and the Structured Inventory for Malingered Symptomatology (SIMS) online. After two weeks, 66 participants completed the SVC again. We evaluated the factor structure, internal consistency, convergent and divergent validity, and test-retest reliability of the SVC.RESULTS: The sample was split in two subsamples to perform exploratory and confirmatory factor analyses. In the first subsample, the exploratory factor analysis extracted three factors from the SVC: diminished visual perception, altered visual perception and ocular discomfort. The confirmatory factor analysis showed this model to be valid in the second subsample. The SVC showed satisfactory convergent validity (NEI-VFQ-25: r = -0.71; CVC-q: r = 0.84) and divergent validity (SIMS: r = 0.26; BRIEF-A: r = 0.29; FEDA: r = 0.40; DASS-21: r = 0.34) and good internal consistency (Cronbach's alpha = 0.85) and test-retest reliability (ICC = 0.82).CONCLUSIONS: The SVC is a valid and reliable tool for the assessment of subjective visual complaints in a community sample and appears promising for clinical use in patients with neurodegenerative disorders.

AB - BACKGROUND AND OBJECTIVES: Patients with neurodegenerative disorders often experience impairments in visual function. In research and clinical care, visual problems are primarily understood as objective visual impairments. Subjective complaints, referring to complaints from a patient's perspective, receive less attention, while they are of utmost clinical importance to guide assessment and rehabilitation. A 21-item Screening of Visual Complaints questionnaire (SVC) was developed for the assessment of subjective visual complaints in patients with neurodegenerative disorders. This prospective study aims to evaluate the psychometric properties of the SVC in a large community sample.METHODS: A stratified convenience sample of 1,461 healthy Dutch participants (18-95 years) without severe self-reported neurological, ophthalmological or psychiatric conditions completed the SVC, Cerebral Visual Complaints questionnaire (CVC-q), National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25), Behavior Rating Inventory of Executive Function-A (BRIEF-A), Questionnaire for Experiences of Attention Deficits (Fragebogen erlebter Defizite der Aufmerkzamkeit; FEDA), Depression Anxiety Stress Scale-21 (DASS-21) and the Structured Inventory for Malingered Symptomatology (SIMS) online. After two weeks, 66 participants completed the SVC again. We evaluated the factor structure, internal consistency, convergent and divergent validity, and test-retest reliability of the SVC.RESULTS: The sample was split in two subsamples to perform exploratory and confirmatory factor analyses. In the first subsample, the exploratory factor analysis extracted three factors from the SVC: diminished visual perception, altered visual perception and ocular discomfort. The confirmatory factor analysis showed this model to be valid in the second subsample. The SVC showed satisfactory convergent validity (NEI-VFQ-25: r = -0.71; CVC-q: r = 0.84) and divergent validity (SIMS: r = 0.26; BRIEF-A: r = 0.29; FEDA: r = 0.40; DASS-21: r = 0.34) and good internal consistency (Cronbach's alpha = 0.85) and test-retest reliability (ICC = 0.82).CONCLUSIONS: The SVC is a valid and reliable tool for the assessment of subjective visual complaints in a community sample and appears promising for clinical use in patients with neurodegenerative disorders.

U2 - 10.1371/journal.pone.0232232

DO - 10.1371/journal.pone.0232232

M3 - Article

C2 - 32348342

VL - 15

JO - PLOS-One

JF - PLOS-One

SN - 1932-6203

IS - 4

M1 - e0232232

ER -

ID: 103420972